Charles Schwab’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.78M Buy
176,850
+28,214
+19% +$948K ﹤0.01% 2422
2025
Q4
$6.37M Sell
148,636
-31,172
-17% -$1.18M ﹤0.01% 2340
2025
Q3
$5.09M Buy
179,808
+102,317
+132% +$3.06M ﹤0.01% 2433
2025
Q2
$1.45M Buy
77,491
+11,154
+17% +$211K ﹤0.01% 2771
2025
Q1
$1.19M Sell
66,337
-11,070
-14% -$225K ﹤0.01% 2781
2024
Q4
$1.3M Hold
77,407
﹤0.01% 2818
2024
Q3
$1.25M Sell
77,407
-2
-0% -$24 ﹤0.01% 2853
2024
Q2
$636K Buy
77,409
+3,047
+4% +$31.9K ﹤0.01% 3092
2024
Q1
$1.1M Hold
74,362
﹤0.01% 2766
2023
Q4
$1.08M Sell
74,362
-12,059
-14% -$123K ﹤0.01% 2802
2023
Q3
$933K Hold
86,421
﹤0.01% 2823
2023
Q2
$1.11M Sell
86,421
-211
-0.2% -$2.85K ﹤0.01% 2731
2023
Q1
$1.14M Buy
86,632
+6,562
+8% +$104K ﹤0.01% 2693
2022
Q4
$1.2M Sell
80,070
-6,889
-8% -$63.2K ﹤0.01% 2721
2022
Q3
$1.03M Buy
86,959
+224
+0.3% +$3.03K ﹤0.01% 2786
2022
Q2
$981K Sell
86,735
-334
-0.4% -$6.71K ﹤0.01% 2807
2022
Q1
$2.6M Buy
87,069
+2,776
+3% +$75.2K ﹤0.01% 2553
2021
Q4
$2.23M Buy
84,293
+906
+1% +$27.3K ﹤0.01% 2671
2021
Q3
$3.03M Buy
83,387
+40,656
+95% +$1.6M ﹤0.01% 2600
2021
Q2
$1.85M Sell
42,731
-360
-0.8% -$13.6K ﹤0.01% 2743
2021
Q1
$1.47M Buy
43,091
+1,378
+3% +$54.6K ﹤0.01% 2729
2020
Q4
$1.46M Buy
41,713
+1,682
+4% +$48.7K ﹤0.01% 2681
2020
Q3
$961K Sell
40,031
-1,648
-4% -$40.5K ﹤0.01% 2688
2020
Q2
$763K Buy
41,679
+1,369
+3% +$24.6K ﹤0.01% 2706
2020
Q1
$629K Sell
40,310
-14
-0% -$298 ﹤0.01% 2634
2019
Q4
$863K Hold
40,324
﹤0.01% 2645
2019
Q3
$755K Hold
40,324
﹤0.01% 2650
2019
Q2
$1.05M Buy
40,324
+2,499
+7% +$56.4K ﹤0.01% 2559
2019
Q1
$973K Buy
37,825
+1,102
+3% +$25.2K ﹤0.01% 2562
2018
Q4
$845K Hold
36,723
﹤0.01% 2591
2018
Q3
$1.18M Buy
36,723
+1,143
+3% +$34.3K ﹤0.01% 2569
2018
Q2
$1.01M Buy
35,580
+5,530
+18% +$197K ﹤0.01% 2582
2018
Q1
$1.06M Buy
30,050
+130
+0.4% +$5.2K ﹤0.01% 2498
2017
Q4
$1.16M Buy
29,920
+3,120
+12% +$119K ﹤0.01% 2470
2017
Q3
$681K Hold
26,800
﹤0.01% 2626
2017
Q2
$732K Hold
26,800
﹤0.01% 2567
2017
Q1
$888K Buy
26,800
+6,640
+33% +$169K ﹤0.01% 2458
2016
Q4
$480K Hold
20,160
﹤0.01% 2666
2016
Q3
$740K Hold
20,160
﹤0.01% 2487
2016
Q2
$450K Hold
20,160
﹤0.01% 2625
2016
Q1
$420K Hold
20,160
﹤0.01% 2644
2015
Q4
$611K Hold
20,160
﹤0.01% 2556
2015
Q3
$498K Hold
20,160
﹤0.01% 2628
2015
Q2
$648K Sell
20,160
-9,375
-32% -$358K ﹤0.01% 2578
2015
Q1
$1.05M Hold
29,535
﹤0.01% 2352
2014
Q4
$671K Sell
29,535
-276
-0.9% -$5.58K ﹤0.01% 2516
2014
Q3
$579K Sell
29,811
-7,285
-20% -$206K ﹤0.01% 2532
2014
Q2
$1.35M Buy
37,096
+12,999
+54% +$442K ﹤0.01% 2195
2014
Q1
$935K Buy
24,097
+570
+2% +$20.3K ﹤0.01% 2323
2013
Q4
$671K Buy
23,527
+684
+3% +$20.1K ﹤0.01% 2462
2013
Q3
$823K Buy
22,843
+3,386
+17% +$124K ﹤0.01% 2309
2013
Q2
$654K Buy
+19,457
New +$882K ﹤0.01% 2390

Other funds holding RIGL